Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Chiao Cheng

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Techniques in Coloproctology|October 27, 2021
Early botulinum toxin injection reduces pain after hemorrhoidectomy: a pilot studyYi-Chiao Cheng, Jacqueline Yu-Min Beh, Po-Hsien Wu, et al.
Therapeutic Advances in Gastroenterology|May 21, 2025
Clinical insights into IL-23 inhibition: risankizumab for Crohn's disease through a systematic review and meta-analysis of randomized controlled trialsPo-Feng Huang, Tien-Yu Huang, Yi-Chiao Cheng, et al.
Annals of Transplantation|July 1, 2014
Transarterial chemoembolization for intrahepatic multiple recurrent HCC after liver resection or transplantationYi-Chiao Cheng, Teng-Wei Chen, Hsiu-Lung Fan, et al.
Medicine|May 26, 2023
Association between nonalcoholic fatty liver disease and colorectal cancer: A population-based studyPo-Hsien Wu, Chi-Hsiang Chung, Ying-Hsiang Wang, et al.
Intestinal Research|February 19, 2024
Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort studyYing-Hsiang Wang, Chi-Hsiang Chung, Tien-Yu Huang, et al.
European Journal of Pharmacology|September 5, 2025
Antrocinol-Mediated Downregulation of ATG5 Induces Autophagy-Dependent Cell Death and Activates the Unfolded Protein Response Through PERK/CHOP Signaling in Lenvatinib-Resistant Hepatocellular Carcinoma CellsShiue-Wei Lai, Yi-Chiao Cheng, Ming-Shou Hsieh, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 9, 2026
Targeting PPP1R15B and ATF4 Axis in Hepatocellular Carcinoma: A Novel Strategy for Overcoming Lenvatinib-Tolerant Persister Cells Through GPX4-Mediated Ferroptosis InductionMing-Yao Chen, Shiue-Wei Lai, Yi-Chiao Cheng, et al.
Translational Oncology|January 17, 2025
Targeting FABP4/UCP2 axis to overcome cetuximab resistance in obesity-driven CRC with drug-tolerant persister cellsYi-Chiao Cheng, Ming-Yao Chen, Vijesh Kumar Yadav, et al.
International Journal of Molecular Sciences|January 28, 2026
SIAH2-WNK1 Signaling Drives Glycolytic Metabolism and Therapeutic Resistance in Colorectal CancerKee-Thai Kiu, Cheng-Ying Chu, Yi-Chiao Cheng, et al.
Aging|October 14, 2023
Dysregulated expression of slingshot protein phosphatase 1 (SSH1) disrupts circadian rhythm and WNT signaling associated to hepatocellular carcinoma pathogenesisShiue-Wei Lai, Yi-Chiao Cheng, Wen-Chien Huang, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Techniques in Coloproctology|October 27, 2021
Early botulinum toxin injection reduces pain after hemorrhoidectomy: a pilot studyYi-Chiao Cheng, Jacqueline Yu-Min Beh, Po-Hsien Wu, et al.
Therapeutic Advances in Gastroenterology|May 21, 2025
Clinical insights into IL-23 inhibition: risankizumab for Crohn's disease through a systematic review and meta-analysis of randomized controlled trialsPo-Feng Huang, Tien-Yu Huang, Yi-Chiao Cheng, et al.
Annals of Transplantation|July 1, 2014
Transarterial chemoembolization for intrahepatic multiple recurrent HCC after liver resection or transplantationYi-Chiao Cheng, Teng-Wei Chen, Hsiu-Lung Fan, et al.
Medicine|May 26, 2023
Association between nonalcoholic fatty liver disease and colorectal cancer: A population-based studyPo-Hsien Wu, Chi-Hsiang Chung, Ying-Hsiang Wang, et al.
Intestinal Research|February 19, 2024
Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort studyYing-Hsiang Wang, Chi-Hsiang Chung, Tien-Yu Huang, et al.
European Journal of Pharmacology|September 5, 2025
Antrocinol-Mediated Downregulation of ATG5 Induces Autophagy-Dependent Cell Death and Activates the Unfolded Protein Response Through PERK/CHOP Signaling in Lenvatinib-Resistant Hepatocellular Carcinoma CellsShiue-Wei Lai, Yi-Chiao Cheng, Ming-Shou Hsieh, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 9, 2026
Targeting PPP1R15B and ATF4 Axis in Hepatocellular Carcinoma: A Novel Strategy for Overcoming Lenvatinib-Tolerant Persister Cells Through GPX4-Mediated Ferroptosis InductionMing-Yao Chen, Shiue-Wei Lai, Yi-Chiao Cheng, et al.
Translational Oncology|January 17, 2025
Targeting FABP4/UCP2 axis to overcome cetuximab resistance in obesity-driven CRC with drug-tolerant persister cellsYi-Chiao Cheng, Ming-Yao Chen, Vijesh Kumar Yadav, et al.
International Journal of Molecular Sciences|January 28, 2026
SIAH2-WNK1 Signaling Drives Glycolytic Metabolism and Therapeutic Resistance in Colorectal CancerKee-Thai Kiu, Cheng-Ying Chu, Yi-Chiao Cheng, et al.
Aging|October 14, 2023
Dysregulated expression of slingshot protein phosphatase 1 (SSH1) disrupts circadian rhythm and WNT signaling associated to hepatocellular carcinoma pathogenesisShiue-Wei Lai, Yi-Chiao Cheng, Wen-Chien Huang, et al.
Pageof 3